EUVIMEDEUVIMED entdecken
Klinische StudieOpen Access · CC BY 4.0

Effects of Azithromycin on Blood Inflammatory Gene Expression and Cytokine Production in Sarcoidosis

Simon D Fraser, Susannah Thackray-Nocera, Caroline Wright, Rachel Flockton, Sally R James, Michael G Crooks, Paul M Kaye, Simon P Hart

Lung · 2024

DOI: 10.1007/s00408-024-00743-w ↗

Kurz gefasst

Klinische Studie in der Zeitschrift Lung, 2024. Verfasst von Simon D Fraser und 7 weiteren Autor:innen. Beteiligte Einrichtung: Respiratory Research Group, Hull York Medical School, Castle Hill Hospital, Cottingham, HU16 5JQ, UK. Hauptthemen laut MEDLINE: Azithromycin, Sarcoidosis, Pulmonary, Cytokines. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, SarcoidosisUK, Nanostring.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

In sarcoidosis granulomas, monocyte-derived macrophages are activated by pro-inflammatory cytokines including TNF and IL-6. Current drug treatment for sarcoidosis aims to suppress inflammation but disabling side effects can ensue. The macrolide azithromycin may be anti-inflammatory. We aimed to determine whether treatment with azithromycin affects blood inflammatory gene expression and monocyte functions in sarcoidosis.

Methods

Blood samples were collected from patients with chronic pulmonary sarcoidosis enrolled in a single arm, open label clinical trial who received oral azithromycin 250 mg once daily for 3 months. Whole blood inflammatory gene expression with or without LPS stimulation was measured using a 770-mRNA panel. Phenotypic analysis and cytokine production were conducted by flow cytometry and ELISA after 24h stimulation with growth factors and TLR ligands. mTOR activity was assessed by measuring phosphorylated S6RP.

Results

Differential gene expression analysis indicated a state of heightened myeloid cell activation in sarcoidosis. Compared with controls, sarcoidosis patients showed increased LPS responses for several cytokines and chemokines. Treatment with azithromycin had minimal effect on blood gene expression overall, but supervised clustering analysis identified several chemokine genes that were upregulated. At the protein level, azithromycin treatment increased LPS-stimulated TNF and unstimulated IL-8 production. No other cytokines showed significant changes following azithromycin. Blood neutrophil counts fell during azithromycin treatment whereas mononuclear cells remained stable. Azithromycin had no detectable effects on mTOR activity or activation markers.

Conclusion

Blood myeloid cells are activated in sarcoidosis, but azithromycin therapy did not suppress inflammatory gene expression or cytokine production in blood.

Trial registration

EudraCT 2019-000580-24 (17 May 2019)

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AzithromycinSarcoidosis, PulmonaryCytokinesHumansMiddle AgedFemaleMaleAdultInterleukin-8TOR Serine-Threonine KinasesTumor Necrosis Factor-alphaAnti-Inflammatory AgentsLipopolysaccharidesMonocytesGene ExpressionAgedInflammation Mediators

Stichwörter der Autor:innen

CoughCytokinesInflammationInnate immunityMonocyteSarcoidosis

Substanzen

AzithromycinCytokinesInterleukin-8TOR Serine-Threonine KinasesTumor Necrosis Factor-alphaAnti-Inflammatory AgentsLipopolysaccharidesMTOR protein, humanInflammation MediatorsCXCL8 protein, human

Autor:innen und Institutionen

  • Respiratory Research Group, Hull York Medical School, Castle Hill Hospital, Cottingham, HU16 5JQ, UK.
  • Respiratory Clinical Trials Unit, Hull University Teaching Hospitals NHS Trust, Castle Hill Hospital, Cottingham, HU16 5JQ, UK.
  • Biosciences Technology Facility, Dept. of Biology, University of York, York, UK.
  • York Biomedical Research Institute, University of York, York, YO10 5DD, UK.
  • Respiratory Research Group, Hull York Medical School, Castle Hill Hospital, Cottingham, HU16 5JQ, UK. s.hart@hull.ac.uk.

Förderung

  • Wellcome Trust
  • SarcoidosisUK
  • Nanostring
  • Myriad-RBM

Zitieren

APA

Fraser, S. D., Thackray-Nocera, S., Wright, C., Flockton, R., James, S. R., Crooks, M. G., Kaye, P. M., & Hart, S. P. (2024). Effects of Azithromycin on Blood Inflammatory Gene Expression and Cytokine Production in Sarcoidosis. Lung. https://doi.org/10.1007/s00408-024-00743-w

Vancouver

Fraser SD, Thackray-Nocera S, Wright C, Flockton R, James SR, Crooks MG, et al. Effects of Azithromycin on Blood Inflammatory Gene Expression and Cytokine Production in Sarcoidosis. Lung. 2024. doi:10.1007/s00408-024-00743-w

BibTeX
@article{Fraser2024,
  author = {Fraser, Simon D and Thackray-Nocera, Susannah and Wright, Caroline and Flockton, Rachel and James, Sally R and Crooks, Michael G and Kaye, Paul M and Hart, Simon P},
  title = {Effects of Azithromycin on Blood Inflammatory Gene Expression and Cytokine Production in Sarcoidosis},
  journal = {Lung},
  year = {2024},
  doi = {10.1007/s00408-024-00743-w}
}
Kostenlos starten →